°¨¿°Áúȯ(Infectious Disease)¿¡ ´ëÇÑ Á¤ºÎ¿Í ¹Î°£ÀÇ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ °¨¿°Áúȯ °ü·Ã ¾÷°è ¶ÇÇÑ È°È²À» ¶ì°í ÀÖ½À´Ï´Ù. Áúº´ °Ë»ç, ¹é½Å, Ä¡·á¹ý, ¿¬±¸°³¹ß(R&D)¿¡ ´ëÇÑ ¸ðµç Á¤º¸ ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ ÃֽŠÁ¶»ç º¸°í¼¸¦ ±¸ºñÇÏ°í °ü·Ã ±â¼ú°ú ½ÃÀå¿¡ ´ëÇÑ ÃֽŠÁ¤º¸¸¦ ÀüÇص帮°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ Ç×Áø±ÕÁ¦ ½ÃÀå Æò°¡ : ¾àÁ¦ Ŭ·¡½ºº°, ÀûÀÀÁõº°, Åõ¿© °æ·Îº°, ¾àÁ¦º°, À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, ±âȸ, ¿¹Ãø(2018-2032³â)
Antifungal Drugs Market Assessment, By Drug Class, By Indication, By Route of Administration, By Medication, By Type, By Distribution Channel, By Region, Opportunities and Forecast, 2018-2032F
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 4,500
£Ü 6,624,000 (ºÎ°¡¼¼ º°µµ)
|
°¨¿°Áõ Ä¡·áÁ¦ ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® - À¯Çüº°, Ä¡·á¹ýº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2024-2031³â)
Infectious Disease Therapeutics Market Size, Share, Growth Analysis, By Type (HIV, Hepatitis), By Treatment (Antibacterial, Antifungal Drugs), By Region - Industry Forecast 2024-2031
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 5,300
£Ü 7,802,000 (ºÎ°¡¼¼ º°µµ)
|
±Í °¨¿° Ä¡·á ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, °¨¿° À¯Çüº°, ¾à¹° À¯Çüº°, Áö¿ªº° - »ê¾÷º° ¿¹Ãø(2024-2031³â)
Ear Infection Treatment Market Size, Share, Growth Analysis, By Infection Type (Outer Ear, Middle Ear), By Drug Type (Analgesics, Antibiotics), By Region - Industry Forecast 2024-2031
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 5,300
£Ü 7,802,000 (ºÎ°¡¼¼ º°µµ)
|
¼ö¸·¿°±Õ ¹é½Å ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : ¹é½Å À¯Çüº°, ºê·£µåº°, ¿¬·ÉÃþº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2024-2031³â)
Meningococcal Vaccines Market Size, Share, Growth Analysis, By Vaccine Type (Polysaccharide Vaccines, Conjugate Vaccines), By Brand (Menactra, Menveo), By Age Group, By End User, By Region - Industry Forecast 2024-2031
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 5,300
£Ü 7,802,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÀÎÇ÷翣ÀÚ Áø´Ü ½ÃÀå : ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, Á¦Ç°º°, °Ë»çº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ¾÷°è ¿¹Ãø(2024-2031³â)
Influenza Diagnostics Market Size, Share, Growth Analysis, By Product (Test kit & Reagents, Instruments), By Test (Molecular Diagnostic Test, Transcription Mediated Amplification Based Assay), By End User, By Region - Industry Forecast 2024-2031
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 5,300
£Ü 7,802,000 (ºÎ°¡¼¼ º°µµ)
|
Ç×´º·ÎÇʶó¸àÆ® L Ç×ü ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¼¼°è ºÐ¼®
Anti Neurofilament L Antibody Market Forecasts to 2030 - Global Analysis By Product Type (Monoclonal Antibodies, Polyclonal Antibodies and Other Product Types), Application, End User and By Geography
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 4,150
£Ü 6,109,000 (ºÎ°¡¼¼ º°µµ)
|
Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Antiviral Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 4,995
£Ü 7,353,000 (ºÎ°¡¼¼ º°µµ)
|
¼Ò °áÇÙ Áø´Ü ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Bovine Tuberculosis Diagnosis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 4,995
£Ü 7,353,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ µ±â¿ ¹é½Å ½ÃÀå º¸°í¼(2024³â)
Dengue Vaccine Global Market Report 2024
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 4,000
£Ü 5,888,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¿ä·Î °¨¿°Áõ °Ë»ç ½ÃÀå : ÀûÀÀÁõº°, °Ë»ç Å°Æ®º°, °Ë»ç Ç׸ñº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)
Urinary Tract Infection Testing Market by Indication (Cystitis, Pyelonephritis, Urethritis), Test Kits (Home Test Kits, Laboratory Test Kits), Tests, End User - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÀǾàÇ°¿¡¼ Áö¼Ó°¡´ÉÇÑ µð¹ÙÀ̽º ½ÃÀå : À¯Çüº°, Àç·á ±¸¼ºº°, ÃÖÁ¾ ¿ëµµº°-¿¹Ãø(2025-2030³â)
Sustainable Devices in Pharmaceutical Market by Type (Diagnostic Devices, Drug Delivery Devices, Packaging Material), Material Composition (Biodegradable Material, Recyclable Plastics, Renewable Material), End-use - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
¼º °¨¿°Áõ Áø´Ü ½ÃÀå : Áúȯ À¯Çü, Áø´Ü ¹æ¹ý, µð¹ÙÀ̽º À¯Çü, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Sexually Transmitted Disease Diagnostics Market by Disease Type, Diagnostic methods, Device Type, End-Users - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
Æó·Å±¸±Õ ¹é½Å ½ÃÀå : À¯Çüº°, ÀûÀÀÁõº°, ¿¬·ÉÃþº°, ºÐÆ÷º° - ¼¼°è ¿¹Ãø(2025-2030³â)
Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Age Group, Distribution - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ´ÙÁ¦³»¼º °áÇÙ Ä¡·áÁ¦ ½ÃÀå : Á¦Ç°, Åõ¿© ¹æ¹ý, À¯Åë ä³Îº° ¿¹Ãø(2025-2030³â)
Multidrug-resistant Tuberculosis Therapeutics Market by Offering (Medication, Therapies), Mode of Administration (Injectable Medications, Oral Medications), Distribution Channel - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¸ÞƼ½Ç¸° ³»¼º Ȳ»öÆ÷µµ»ó±¸±Õ Ä¡·áÁ¦ ½ÃÀå : ¾àÁ¦ À¯Çü, Åõ¿© °æ·Î, ÆǸŠä³Îº° ¿¹Ãø(2025-2030³â)
Methicillin-Resistant Staphylococcus Aureus Drugs Market by Agent Type (Ceftaroline, Daptomycin, Linezolid), Route of Administration (Oral, Parenteral), Sales Channel - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ MAXIGESIC IV ½ÃÀå : ½ÃÀå ±Ô¸ð, ¿¹Ãø, »õ·Î¿î ÀλçÀÌÆ®(-2032³â)
MAXIGESIC IV Market Size, Forecast, and Market Insight - 2032
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 2,750
£Ü 4,048,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Ç×±ÕÁ¦ ³»¼º °¨½Ã ½ÃÀå : ÄÄÆ÷³ÍÆ®º°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)
Antimicrobial Resistance Surveillance Market by Component (Diagnostic Kits, Diagnostic Systems, Services), End-User (Hospitals, Research & Academic Institutes) - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¾Æ¼¼ÅäÇÏÀ̵å·Ï»ï»ê ½ÃÀå : Á¦Á¦º°, À¯Åë ä³Îº°, ¿ëµµº° - ¿¹Ãø(2025-2030³â)
Acetohydroxamic Acid Market by Formulation (Liquid, Tablets/Capsules), Distribution Channel (Hospital Pharmacies, Online Pharmacies), Application - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¹ÝÄÚ¸¶À̽Š½ÃÀå : À¯Çü, Åõ¿©Çü, Åõ¿© °æ·Î, ¿ëµµ, À¯Åë ä³Îº° ¿¹Ãø(2025-2030³â)
Vancomycin Market by Type (Ampicillin, Chloramphenicol, Daptomycin), Form (Capsule, Oral Solution (Liquid), Powder), Route of Administration, Application, Distribution Channel - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå : Á¦Ç° À¯Çü, ÆäÀÌÁî, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)
Surgical Site Infection Control Market by Product (Antibiotic Prophylaxis Products, Antiseptics & Disinfectants, Clippers), Type (Deep Incisional Infection, Space Infection, Superficial Incisional Infection), Phase, End-user - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¼³Æù¾Æ¹Ìµå ½ÃÀå : ÇüÅÂ, Åõ¿© °æ·Î, À¯Åë ä³Î, ¿ëµµº° ¿¹Ãø(2025-2030³â)
Sulphonamides Market by Form (Capsule, Liquid, Powder), Route of Administration (Oral, Topical), Distribution Channel, Application - Global Forecast 2025-2030
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,939
£Ü 5,798,000 (ºÎ°¡¼¼ º°µµ)
|
Leronlimab ½ÃÀå ±Ô¸ð, ¿¹Ãø, ½Å¾à ÀλçÀÌÆ®(2032³â)
Leronlimab Market Size, Forecast, and Emerging Insight - 2032
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 3,250
£Ü 4,784,000 (ºÎ°¡¼¼ º°µµ)
|
¿¥Æø½º - °æÀï ±¸µµ(2024³â)
Monkeypox - Competitive Landscape, 2024
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 2,000
£Ü 2,944,000 (ºÎ°¡¼¼ º°µµ)
|
¿¡º¼¶ó ¹ÙÀÌ·¯½º - °æÀï ±¸µµ(2024³â)
Ebola Virus- Competitive Landscape, 2024
¹ßÇà 2024³â 12¿ù
°¡°Ý
US $ 2,000
£Ü 2,944,000 (ºÎ°¡¼¼ º°µµ)
|
µ±â¿ ½ÃÀå : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2024³â)
Dengue Fever - Global Clinical Trials Review, 2024
¹ßÇà 2024³â 11¿ù
°¡°Ý
US $ 3,450
£Ü 5,078,000 (ºÎ°¡¼¼ º°µµ)
|